Quarterly report pursuant to Section 13 or 15(d)

OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)

v3.20.1
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)
3 Months Ended
Mar. 31, 2020
Disclosure Text Block Supplement [Abstract]  
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]
The following table presents information related to stock options at March 31, 2020:


 

Options Outstanding

   

Options Exercisable

 
                 

Weighted

         
                 

Average

   

Exercisable

 
 

Exercise

   

Number of

   

Remaining Life

   

Number of

 
 

Price

   

Options

   

In Years

   

Options

 
  $ 2.51-5.00       1,666,695       7.6       1,231,699  
    5.01-7.500       1,856,230       5.8       1,329,943  
    7.51-10.00       305,971       7.4       168,470  
            3,828,896       6.7       2,730,112  
 

Options Outstanding

   

Options Exercisable

 
                 

Weighted

         
                 

Average

   

Exercisable

 
 

Exercise

   

Number of

   

Remaining Life

   

Number of

 
 

Price

   

Options

   

In Years

   

Options

 
  $ 5.00       575,000       9.5       575,000  
Share-based Payment Arrangement, Option, Activity [Table Text Block]
A summary of the stock option activity and related information for the Plan for the three months ended March 31, 2020 is as follows:


                   

Weighted-Average

         
           

Weighted-Average

   

Remaining

   

Aggregate

 
   

Shares

   

Exercise Price

   

Contractual Term

   

Intrinsic Value

 

Outstanding at January 1, 2020

    3,980,804     $ 5.58       6.3     $ 3,130,791  

Grants

    210,000       4.01       10.0     $ -  

Exercised

    (309,630

)

  $ 5.23       0.00          

Forfeited/expired

    (52,278

)

  $ 6.49                  

Outstanding at March 31, 2020

    3,828,896     $ 5.54       6.72     $ 389,031  

Exercisable at March 31, 2020

    2,730,112     $ 5.66       5.40     $ 268,481  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

Risk-free interest rate

    0.55% - 1.83

%

Dividend yield

    0

%

Stock price volatility

    86.51% to 90.42

%

Expected life

 

6 – 10 years

 

Weighted average grant date fair value

  $ 3.73  
Schedule of Warrants or Rights, Shares Authorized, by Exercise Price Range [Table Text Block]
The following table summarizes information with respect to outstanding warrants to purchase common stock of BioSig Technologies, Inc. at March 31, 2020:


 

Exercise

   

Number

 

Expiration

 

Price

   

Outstanding

 

Date

  $ 3.75       461,325  

April 2020 to January 2021

  $ 4.375       602,272  

April 2021 to May 2021

  $ 4.80       125,000  

February 2025

  $ 6.16       568,910  

November 2027

  $ 6.85       205,523  

July 2021 to August 2021

            1,963,030    
 

Exercise

   

Number

 

Expiration

 

Price

   

Outstanding

 

Date

  $ 5.00       473,772  

November 2027

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
A summary of the warrant activity for the three months ended March 31, 2020 is as follows:


 

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

Remaining

 

 

Aggregate

 

 

 

Shares

 

 

Exercise Price

 

 

Contractual Term

 

 

Intrinsic Value

 

Outstanding at January 1, 2020

 

 

2,744,718

 

 

$

5.40

 

 

 

2.2

 

 

$

3,410,763

 

Grants

 

 

125,000

 

 

 

4.80

 

 

 

5.0

 

 

 

 

 

Exercised

 

 

(112,792

)

 

$

3.83

 

 

 

 

 

 

 

 

 

Expired

 

 

(793,896

)

 

$

6.45

 

 

 

-

 

 

 

-

 

Outstanding at March 31, 2020

 

 

1,963,030

 

 

$

5.03

 

 

 

3.1

 

 

$

202,983

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest at March 31, 2020

 

 

1,963,030

 

 

$

5.03

 

 

 

3.1

 

 

$

202,983

 

Exercisable at March 31, 2020

 

 

1,963,030

 

 

$

5.03

 

 

 

3.1

 

 

$

202,983

 

   

Shares

   

Weighted-Average Exercise Price

   

Weighted-Average Remaining Contractual Term

   

Aggregate Intrinsic Value

 

Outstanding at January 1, 2020

    473,772     $ 5.00       7.9     $ -  

Grants

    -                          

Exercised

    -                          

Expired

    -                          

Outstanding at March 31, 2020

    473,772     $ 5.00       7.6     $ -  
                                 

Vested and expected to vest at March 31, 2020

    473,772     $ 5.00       7.6     $ -  

Exercisable at March 31, 2020

    473,772     $ 5.00       7.6     $ -  
Nonvested Restricted Stock Shares Activity [Table Text Block]
The following table summarizes the restricted stock activity for the three months ended March 31, 2020:


Restricted shares issued as of January 1, 2020

    262,668  

Granted

    -  

Vested

    (81,334

)

Vested restricted shares as of March 31, 2020

    -  

Unvested restricted shares as of March 31, 2020

    181,334  

Restricted shares issued as of January 1, 2020

    40,000  

Granted

    1,298,000  

Vested

    -  

Vested restricted shares as of March 31, 2020

    658,000  

Unvested restricted shares as of March 31, 2020

    680,000